" class="no-js "lang="en-US"> Rob ten Hoedt - Medtech Alert
Sunday, February 05, 2023

Breaking News

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Rob ten Hoedt

Rob ten Hoedt

About Rob ten Hoedt

Related Story

Equipment

 Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval | Pharmtech Focus

Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval

October 11 2021

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité […]